Vivimed Labs Ltd

Stage 1 · Basing · week 6

As of 16 Oct 2026, Vivimed Labs is in Stage 1 — basing, not yet in an uptrend, in week 6 (since 8 Sep 2026). It closed at ₹6.58, 75.3% below its 52-week high and below its 200-day average, which is falling. In Materials, 34.1% of stocks are in Stage 2.

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. More about the company

₹6.6
-1.94% today
₹55 Cr · Micro cap
Market Neutral — FadingMaterials 34.1% in Stage 2-2.9 pts / 20dSpecialty Chemicals 44.9%-3.4 pts

Pro read

Pro

Our read

Basing — not in an uptrend yet

Setup score

—

Momentum

Steady

Edge

—

Is VIVIMEDLAB early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-75.3%
₹4.9 lo₹26.6 hi
75.3% below 52W high
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 6
1w13w26w
Week 6 — early base, needs time
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
-6.3%
200 DMA: ₹7 · sloping down
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.16x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↑
MA20 trending up · +4.7% vs MA50 +6.5%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+13.4%
3M
+25.8%
6M
-11.0%
YTD
-72.6%
1Y
+32.9%
Sector
Materials
↓ Peaking
Stage 2%
34.1%
20d Δ
-2.9pp
1M return
-1.6%
3M return
-2.6%
Sector Stage-2 % · last 20 days
Sector has 153 Stage 2 leaders. See Materials Stage 2 →
Industry
Specialty Chemicals
↓ Peaking
Stage 2%
44.9%
20d Δ
-3.4pp
1M return
+0.5%
3M return
+9.2%
Industry Stage-2 % · last 20 days
Industry has 39 Stage 2 leaders. See Specialty Chemicals Stage 2 →
Stage Cycle Timeline2023-07-19 → 2026-10-16
S4 126w
S4 18w
2023-07-192026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 126w → S2 11w → S3 9w → S4 18w → S1 6w current
Total tracked: 169 weeks across 5 stage runs.
Scan Membership
Breakout Watch
Latest: 2025-12-18
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding — staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-16S1
Wk 6 · Vol 0.16x
2026-10-15S1
Wk 6 · Vol 0.05x
2026-10-14S1
Wk 5 · Vol 0.04x
2026-10-13S1
Wk 5 · Vol 0.05x
2026-10-12S1
Wk 5 · Vol 1.91x
2026-10-09S1
Wk 5 · Vol 12.99x
2026-10-08S1
Wk 5 · Vol 2.17x
2026-10-07S1
Wk 4 · Vol 0.88x
2026-10-06S1
Wk 4 · Vol 0.39x
2026-10-05S1
Wk 4 · Vol 1.48x
2026-10-01S1
Wk 4 · Vol 0.33x
2026-09-30S1
Wk 4 · Vol 0.22x
Sector Peers — Stage 2All →
OCCLLTD
wk 17 · -16.3% from hi
9.0
MUKANDLTD
wk 21 · -7.5% from hi
8.9
SUNFLAG
wk 3 · -9.3% from hi
8.8
CUBEXTUB
wk 2 · 0.0% from hi
8.7
NRL
wk 17 · 0.0% from hi
8.6
Moving averages & range
50 DMA
₹6
200 DMA
₹7
52W High
₹26.6
52W Low
₹4.9
5D Low
₹6.6
Resistance levels (recent highs)
20d High
₹7.3
60d High
₹7.3
120d High
₹7.3
250d High
₹26.6
Next resistance
+10.2%
to 20d High
Ask the Market AI about VIVIMEDLABAsk →
About this companyMaterials· Specialty Chemicals

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.